Alkem Laboratories Shares in Focus on USFDA OAI Classification
Shares of Alkem Laboratories are likely to remain in focus after the US Food and Drug Administration (USFDA) classified the company’s Amaliya manufacturing facility in...
Tag : US Food & Drug Administration (USFDA)
Zydus Lifesciences Shares in Focus After USFDA Inspection Report
Zydus Lifesciences shares remained in focus after the company received an Establishment Inspection Report (EIR) from the US Food and Drug Administration (USFDA) for its...
Lupin Shares in Focus After USFDA Approval for Injection
Shares of Lupin Ltd were trading in the red and 1% lower on 3 August despite the company announcing that it has secured a US...
Aurobindo Pharma Falls 2% After USFDA Classifies Eugia Unit III as OAI
Shares of Aurobindo Pharma Limited slipped on Monday, 15 June, touching an intraday low of Rs 1,446 on the NSE after the US Food and...
Granules India Climbs 2% as US Unit Bags Clean USFDA Inspection Nod
Shares of Granules India Limited touched a day high of Rs 797.00 on 3 June after the company disclosed that its wholly owned US subsidiary,...
Concord Biotech Jumps 8% After USFDA Clears Key Transplant Drug
Shares of Concord Biotech Limited climbed as much as 8% on 3 June, touching a day high of Rs 1,264.90 on NSE, after the company...
Alembic Pharma Shares Gain 2% on USFDA Tentative Approval
Shares of Alembic Pharmaceuticals witnessed a positive move, gaining 2%, on 14 May after the company secured tentative approval from the US Food and Drug...
Aurobindo Shares Soar 4% as USFDA Classifies Facility as VAI
Shares of Aurobindo Pharma Ltd soared roughly 4% on Wednesday, 6 May, after the company said that the US Food and Drug Administration (USFDA) has...
Biocon Shares Slump 2% as USFDA Issues 5 Observations
Shares of Biocon Ltd fell 2% during the early trading hours on Thursday, 30 April, after the company announced that the US drug regulator had...
Aurobindo Pharma Hits 52-Week High on Twin USFDA Approvals
Shares of Aurobindo Pharma Limited touched a 52-week high of Rs 1,396.60 on the BSE on 20 April, rising 0.79% from the previous close of...